Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Temps réel estimé Cboe Europe 10:25:14 04/09/2026			Varia. 5j.	Varia. 1 janv.
1 859,00 ^GBX	-0,40%		+0,30%	+1,89%

03/09	Haleon négocie un meilleur emplacement en rayon chez Walmart et Target	MT
03/09	Le FTSE 100 progresse légèrement ; le pétrole dépasse les 97 USD	AN

Autres langues

03/09	Global markets live: Apple, Microsoft, Tesla, Google, Uber…
03/09	Haleon Negotiates Better Shelf Placement at Walmart, Target
03/09	Wall Street im dreifachen Würgegriff
03/09	Afternoon Meeting: La triple amenaza que se cierne sobre Wall Street
03/09	Wall Street's Triple Squeeze
03/09	FTSE 100 edges higher; oil rises above USD97
03/09	WINNERS & LOSERS: Hutchmed pens GSK deal; Gem Diamonds back in profit
03/09	Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830
03/09	Hong Kong Stocks Fall on Thursday, Amid Bond Selloff, Rate Fears; HUTCHMED Jumps 14%
03/09	Hutchmed Signs Cancer Treatment Licensing Agreement With GSK; Shares Rise Pre-Bell
03/09	LondonMetric investments; Jet2 eyes Main Market move
03/09	Morning Meeting: Comienzo sombrío de la temporada bursátil de otoño
03/09	Morning Meeting: Trüber Auftakt in den Börsenherbst
03/09	HUTCHMED Licenses Cancer Drug to GSK for Up to $1.30 Billion; Shares Up 12%
03/09	A gloomy start to the autumn trading season
03/09	HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug
03/09	Hutchmed Enters Licensing Agreement With GSK for Cancer Drug
03/09	UK Stocks-Factors to watch on September 3
03/09	Hutchmed Grants GSK Global Rights to KRAS-EGFR Antibody Conjugate Cancer Therapy
03/09	HUTCHMED (China) signs exclusive licensing deal with GSK for investigational cancer drug
01/09	Gsk Advances Mrna Flu Vaccine Candidate to Phase Iii Following Positive Phase Ii Data
01/09	European Stocks Close Mostly Lower in Tuesday Trading; Euro Area Inflation Surges in August
01/09	Global pharma companies that have publicly announced Trump drug pricing agreements
01/09	GSK advances mRNA flu vaccine to phase 3 after positive results
01/09	GSK überführt mRNA-Grippeimpfstoff in die nächste Studienphase